Delivery Order SPE2DB24D6038-SPE2DB24FELRG

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,092.56 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,330,497 units of TOBRADEX Eye Ointment 3.5GM. This delivery order contract falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a prime contractor and pharmaceutical distribution services company, for the supply of Tobradex Eye Ointment 3.5 GM. The $11,837.44 firm fixed price contract has a performance period through March 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is providing these pharmaceutical products to support military treatment programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,546.20 firm-fixed-price contract is for the supply of Tobradex Eye Ointment, a prescription ophthalmic medication. The contract has a completion date of May 14, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Tobradex Eye Ointment 3.5 GM. The $3,244.52 firm-fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical ophthalmic medication supplies to support military treatment facilities and other government healthcare programs. This award is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tobradex Eye Ointment 3.5GM. The contract has a firm fixed price, a ceiling value of $1,108.89, and a period of performance through March 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a $2,545.89 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, with a completion date of February 13, 2023. The contract type is Firm Fixed Price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tobradex Eye Ointment 3.5GM. The contract, valued at $1,572.17, is a Firm Fixed Price Delivery Order with a completion date of January 27, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Tobradex Eye Ointment. The one-year contract has a firm fixed price of $1,247.58 and runs through January 30, 2024. This order is not part of a set-aside program. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Tobradex Eye Ointment. The contract has a firm-fixed price ceiling of $2,021.14 and an ultimate completion date of August 15, 2024. As Amerisourcebergen is a major pharmaceutical distributor, this contract is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
The Defense Logistics Agency awarded a $24,573.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Tobradex eye ointment. As the prime contractor, Amerisourcebergen will supply 3.5 gram tubes of the ointment to meet requirements under the contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order was issued on September 5, 2023 under an existing Amerisourcebergen IDIQ vehicle and runs through September 6, 2023. No...
  • SPE2DB24D6038
    Indefinite Delivery Contract
  • SPE2DB24D6038-SPE2DB24FELRG
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,122.06 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to supply 4,565,592,515 units of Tobradex eye ointment, 3.5 grams. The contract has an ultimate completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, running through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/26/24, 9:22 AM